P2RY12 and diabetes mellitus: Anti-P2Y12 drugs (p ≤ 0.001) and diabetes (p = 0.014) emerged as predictors of poor antiplatelet response after adjusting for age, sex, BMI, and CYP2C19∗2 carriers status.